A common IGF1R gene variant predicts later life breast cancer risk in women with preeclampsia
Open Access
- 4 November 2022
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 197 (1) , 149-159
Abstract
Purpose: Preeclampsia has been inconsistently associated with altered later life risk of cancer. This study utilizes the Nurses’ Health Study 2 (NHS2) to determine if the future risk of breast and non-breast cancers in women who experience preeclampsia is modified by carrying a protective variant of rs2016347, a functional insulin-like growth factor receptor-1 (IGF1R) single nucleotide polymorphism. Methods: This retrospective cohort study completed within the NHS2 evaluated participants enrolled in 1989 and followed them through 2015, with a study population of 86,751 after exclusions. Cox proportional hazards models both with and without the impact of rs2016347 genotype were used to assess the risk of invasive breast cancer, hormone receptor-positive (HR+) breast cancer, and non-breast cancers. Results: Women with preeclampsia had no change in risk of all breast, HR+ breast, or non-breast cancers when not considering genotype. However, women carrying at least one T allele of rs2016347 had a lower risk of HR+ breast cancer, HR 0.67, 95% CI: 0.47–0.97, P = 0.04, with interaction term P = 0.06. For non-breast cancers as a group, women carrying a T allele had an HR 0.76, 95% CI: 0.53–1.08, P = 0.12, with interaction term P = 0.26. Conclusions: This retrospective cohort study found that women with preeclampsia who carry a T allele of IGF1R rs2016347 had a reduced future risk of developing HR+ breast cancer, and a reduced but not statistically significant decreased risk of non-breast cancers suggesting a possible role for the IGF-1 axis in the development of cancer in these women.Keywords
All Related Versions
Funding Information
- National Institutes of Health (U01CA176726, U24CA210990)
This publication has 56 references indexed in Scilit:
- Insulin-like growth factor — Oestradiol crosstalk and mammary gland tumourigenesisBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2013
- Global and regional estimates of preeclampsia and eclampsia: a systematic reviewEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2013
- Associations between insulin-like growth factor I, vascular endothelial growth factor and its soluble receptor 1 in umbilical serum and endothelial cells obtained from normotensive and preeclamptic pregnanciesGrowth Factors, 2013
- The relationship between preeclampsia, pregnancy-induced hypertension and maternal risk of breast cancer: A meta-analysisActa Oncologica, 2012
- Hypertensive diseases in pregnancy and breast cancer riskBritish Journal of Cancer, 2012
- Insulin-like Growth Factor Receptor-1 (IGF-1R) Expression in Normal Breast, Proliferative Breast Lesions, and Breast CarcinomaApplied Immunohistochemistry & Molecular Morphology, 2011
- Expression of IGF1R in normal breast tissue and subsequent risk of breast cancerBreast Cancer Research and Treatment, 2011
- Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studiesThe Lancet Oncology, 2010
- Preeclampsia, Pregnancy-related Hypertension, and Breast Cancer RiskAmerican Journal of Epidemiology, 2007
- Serum IGF-I and IGFBP-3 in healthy pregnancies and patients with preeclampsiaClinical Biochemistry, 2003